Fact CheckerSign in

NCT07695493Not yet recruiting

Acceptability, Quality of Care, Patient Satisfaction, and Cost-effectiveness of Monitoring Provided by Nurses or Physicians for People Using HIV Pre-exposure Prophylaxis

An Open-label Randomized Trial Evaluating the Acceptability, Quality of Care, Patient Satisfaction, and Cost-effectiveness of Monitoring Provided by Nurses or Physicians for People Using HIV Pre-exposure Prophylaxis

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

Assess the quality of care and the satisfaction of patients and caregivers when the monitoring of people on HIV pre-exposure prophylaxis (PrEP) is provided by nurses instead of physicians

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
504 (estimated)
First submitted
6 Jul 2026
Start date
1 Sept 2026
Primary completion date
1 Sept 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
HIV
NCT number
NCT07695493

What you commit to

  • Study type: Interventional
  • Planned participants: 504
  • From 1 Sept 2026 to the primary completion date, 1 Sept 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving nurse care in a hospital setting
  • Deprived of liberty by judicial or administrative decision, or individuals receiving psychiatric care under Article L1121-6 of the French Public Health Code

Other illness

  • Individual with confirmed HIV infection

Lab values

  • Having renal impairment (creatinine clearance \< 60 mL/min)

Other

  • Unable to provide informed consent
  • Not affiliated with a social security system or not covered by State Medical Aid (AME)
  • Under legal guardianship or curatorship

Who the study is looking for

  • Male sex assigned at birth, aged ≥ 18 years
  • Individual at risk of HIV infection
  • Currently receiving PrEP care and willing to continue follow-up in a hospital setting
  • Receiving care at a hospital setting by a physician and not objecting to follow-up by a nurse
  • Having received complete information about the study and having provided a free written informed consent
  • Affiliated with a social security system (beneficiary or entitled individual) or covered by State Medical Aid (AME).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.